Cargando…
Changes in Vascular Permeability and Expression of Different Angiogenic Factors Following Anti-Angiogenic Treatment in Rat Glioma
BACKGROUND: Anti-angiogenic treatments of malignant tumors targeting vascular endothelial growth factor receptors (VEGFR) tyrosine kinase are being used in different early stages of clinical trials. Very recently, VEGFR tyrosine kinase inhibitor (Vetanalib, PTK787) was used in glioma patient in conj...
Autores principales: | Ali, Meser M., Janic, Branislava, Babajani-Feremi, Abbas, Varma, Nadimpalli R. S., Iskander, A. S. M., Anagli, John, Arbab, Ali S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806917/ https://www.ncbi.nlm.nih.gov/pubmed/20090952 http://dx.doi.org/10.1371/journal.pone.0008727 |
Ejemplares similares
-
MRI Tracking of FePro Labeled Fresh and Cryopreserved Long Term In Vitro Expanded Human Cord Blood AC133+ Endothelial Progenitor Cells in Rat Glioma
por: Janic, Branislava, et al.
Publicado: (2012) -
Differential biodistribution of intravenously administered endothelial progenitor and cytotoxic T-cells in rat bearing orthotopic human glioma
por: Varma, Nadimpalli Ravi S, et al.
Publicado: (2013) -
Endothelial Progenitor Cells (EPCs) as Gene Carrier System for Rat Model of Human Glioma
por: Varma, Nadimpalli Ravi S., et al.
Publicado: (2012) -
MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP)
por: Arbab, Ali S, et al.
Publicado: (2011) -
Human Cord Blood-Derived AC133+ Progenitor Cells Preserve Endothelial Progenitor Characteristics after Long Term In Vitro Expansion
por: Janic, Branislava, et al.
Publicado: (2010)